By Babatunde Emmanuel
Following the confirmation of an imported case of Ebola Bundibugyo virus disease in Federal Capital Territory of Nigeria on October 20, 2026, health authorities have commenced contact tracing, with 44 close contacts identified.
Here are 10 things to know about the virus, the outbreak and the measures being taken to prevent further transmission.
1. Nigeria Has Confirmed an Imported Ebola Case
On Tuesday, October 20, 2026, Nigeria confirmed its first case of Ebola Bundibugyo virus disease since 2014. The case was detected in the Federal Capital Territory, Abuja, making Nigeria the fifth country to detect the virus since the current outbreak was declared in the Democratic Republic of the Congo in May 2026.
According to the Federal Ministry of Health and Social Welfare, the patient is a woman who recently arrived in Nigeria from Uganda. She is receiving medical care in isolation.
2. The Virus Is the Bundibugyo Virus
The case detected in Nigeria involves the Bundibugyo virus, which can be traced to an ongoing outbreak in the DRC.
3. What Is Bundibugyo?
Bundibugyo is a type of Ebola-causing virus named after Bundibugyo district in western Uganda where it was first identified during an outbreak in 2007. It belongs to the same family of diseases as Ebola virus disease caused by other Ebola viruses.
According to the WHO’s explanation of Ebola vaccines, different virus species can cause different forms of Ebola disease, a distinction that is important when discussing available vaccines.
4. What Is the Outbreak Status in Nigeria?
According to the Federal Ministry of Health and Social Welfare, 44 close contacts had been identified and were being monitored. While efforts are in place to identify other people who may have been exposed to the virus. The report from WHO also corroborates these findings.
5. How Does It Spread?
Ebola spreads through direct contact with the blood or other body fluids of an infected person who has developed symptoms, or someone who has died from the disease.
According to the WHO, transmission can occur when infectious materials enter the body through broken skin or mucous membranes, including those of the eyes, nose and mouth.
The virus can also spread through contact with objects contaminated with infectious body fluids.
6. How Can Nigerians Protect Themselves?
Based on WHO recommendations, members of the public are advised to avoid direct contact with people suspected or confirmed to have Ebola. It further stressed that the public should not handle the bodies of people who may have died from the disease without appropriate protective measures.
Other measures include; regular handwashing with soap and water and compliance with public health guidance are also important; follow recommended infection prevention and control procedures when attending to suspected or confirmed cases. Individuals with symptoms of the virus are advised to seek guidance from health authorities.
7. What Is the Nigerian Government Doing to Contain the Infection?
According to the information gathered, the Federal Ministry of Health and Social Welfare, the Federal Government, and other relevant authorities are working together to contain the infection and prevent further transmission.
8. Is Nigeria the Only Affected Country?
No, according to the WHO’s outbreak updates, several countries have reported cases associated with the Bundibugyo virus outbreak.
Based on the more recent report by WHO, In Democratic Republic of the Congo, 9,637 cases have been confirmed and 4,646 confirmed deaths, as of October 19. Kenya has Nine confirmed cases and one confirmed death as of October 20.
In Uganda, 20 cases have been confirmed with two confirmed dead. While one imported case was recorded in France, but the patient was discharged in July.
9. Is There a Vaccine Against Ebola Disease?
According to the WHO’s September 9, 2026 guidance on Ebola vaccines, Ebola disease is caused by a group of viruses known as Orthoebolaviruses. Four species are recognised as causes of disease in humans: Ebola virus, Bundibugyo virus, Sudan virus and Taï Forest virus.
Currently, Ervebo is the only licensed and WHO-prequalified vaccine specifically available for the Ebola virus species that causes Ebola virus disease. There is no licensed vaccine specifically for Bundibugyo virus disease.
Although research suggests that Ervebo might offer some protection against Bundibugyo virus disease, there is insufficient evidence to establish its effectiveness in humans. But WHO recommends that the vaccine be used against Bundibugyo virus disease only within a research protocol.
10. Why Should the Public Stay Alert?
According to WHO, the Ebola outbreak which was first confirmed in the Democratic Republic of Congo and Uganda is of the Bundibugyo species of Ebola and it is one for which there is no vaccine or specific treatment.
The Outbreak is occurring in a challenging context: humanitarian crisis and densely populated areas combined with insecurity and high populations and trade movement. Members of the public are advised to solely rely on official updates, avoid spreading unverified information and cooperate with public health authorities.
